Phase II trial of 2-chlorodeoxyadenosine for the treatment of cutaneous T-cell lymphoma. [electronic resource]
Producer: 19960301Description: 906-11 p. digitalISSN:- 0006-4971
- Adult
- Aged
- Antimetabolites, Antineoplastic -- adverse effects
- Bone Marrow Diseases -- chemically induced
- Cladribine -- adverse effects
- Female
- Humans
- Male
- Middle Aged
- Mycosis Fungoides -- drug therapy
- Opportunistic Infections -- etiology
- Sezary Syndrome -- drug therapy
- Skin Neoplasms -- drug therapy
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.